EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
20 articles
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Study reveals how lean people can still have obesity-like metabolism and whether calorie restriction helps reverse this dangerous condition.
Maastricht University investigated whether NA, NAM, and tryptophan together could restore mitochondrial function in physically compromised older adults.
A sponsored 90-day trial of enhanced-absorption quercetin targeting cholesterol, blood sugar, and metabolic age was terminated before completion.
Takeda's Phase 1 trial evaluates the safety and tolerability of TAK-510, a novel injectable agent targeting nausea and vomiting, across escalating doses.
A completed OSU trial investigates whether short-term exercise training can restore impaired mitochondrial cleanup pathways in overweight and obese skeletal muscle.
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
176-person study explored personalized responses to refined carbs, whole grains, and intermittent fasting for optimal glucose control.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
New study reveals how endurance exercise transforms fat-burning brown adipose tissue in just six weeks of training.
20-week study reveals how sequencing HIIT and resistance training affects metabolic health in women with morbid obesity.
New research suggests extending overnight fasting from 10 to 16 hours may enhance muscle's ability to use dietary protein for growth.
43-patient study tracked metabolic changes for 2 years after bariatric surgery, revealing improvements beyond simple weight reduction.
Swiss researchers studied how mTOR protein in fat tissue affects metabolism and insulin function throughout the body.
Phase 4 trial tests whether alirocumab can better control non-HDL cholesterol in high-risk type 2 diabetics failing statin therapy.
Czech study reveals how strategic fasting and ketogenic diets can reprogram harmful fat production in obesity.
A Danish case-control trial uses gold-standard metabolic testing to uncover how mtDNA mutations impair muscle glucose uptake and drive insulin resistance.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
French study reveals how aging influences metabolic responses to cancer, potentially explaining malnutrition patterns in elderly patients.
Cross-sectional study of 93 healthy adults compared cardiovascular risk factors between vegetarian and non-vegetarian dietary patterns.